Organization
Cedars-Sinai UCLA, Los Angeles, CA
2 abstracts
Abstract
4 YEAR EXPERIENCE OF BELIMUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY, IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Org: OMRF, OK City, OK, NSLIJHS, Lake Success, NY, Cedars-Sinai UCLA, Los Angeles, CA, OK Ctr for Arth Ther & Res, Tulsa, OK, SUNY Downstate, Brooklyn, NY,
Abstract
BELIMUMAB (FULLY HUMAN MONOCLONAL ANTIBODY TO BLYS) REDUCED STEROID USE IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS DURING 3 YEARS OF THERAPYOrg: SUNY Downstate, Brooklyn, NY, Cedars-Sinai UCLA, Los Angeles, CA, Univ of AL at Birmingham, Birmingham, AL, OK Center for Arthritis Therapy and Research, Tulsa, NSLIJHS, Lake Success, NY,